Merck Animal Health is pleased to introduce PORCILIS™ ILEITIS. This vaccine is the first that offers a 20-week duration of immunity (DOI) for control of ileitis caused by Lawsonia intracellularis. Ileitis impacts the health and performance of finishing pigs; on average diminishing daily gain by 38 percent and feed efficiency by 27 percent. Given as a single, intramuscular vaccination to … Read More
BIVI Market Ready to Tackle Consumer Concerns
It is no secret within the beef community that a stigma has been created around the use of antibiotics in beef cattle. There is now an almost universal concern among consumers regarding the use of antibiotics and other drugs in animals raised for meat, causing a large producer-consumer disconnect; one that is the perfect catalyst for innovative advances in agricultural … Read More
BIVI Announces New Diagnostic Test at #WPX15
The industry’s first commercially available quantitative polymerase chain reaction (PCR) test for Lawsonia (ileitis) has been developed by Boehringer Ingelheim Vetmedica, Inc. (BIVI) Health Management Center and will become available for testing July 1, 2015. The new test provides producers with bacterial concentration levels, unlike the similar qualitative PCR testing which simply detects for the presence of Lawsonia. BIVI’s announcement … Read More
New Research on Vaccine Solutions for H5N2
A novel approach to developing vaccines that prevent avian influenza was highlighted at the recent One Health Summit, an annual BioKansas conference that shares knowledge to strengthen public safety. With the outbreaks on the rise, the need for a vaccine might be too. Recognizing that animal health can affect human health, the One Health Summit featured a presentation about how … Read More
VaxLiant Adjuvants Vaccines Gets USDA Approval
The USDA has approved the safety of four new, ready-to-use ENABL® adjuvants from VaxLiant® that can be added to vaccines to help improve the resulting immune response in cattle and swine. This follows approval of six ENABL adjuvants for swine and cattle vaccines in 2014. All of these approvals include a 21-day withdrawal period when ENABL is used in vaccines … Read More
BIVI Swine Vaccine Available in a 50-dose Presentation
Boehringer Ingelheim Vetmedica, Inc. (BIVI) makes it easier for producers and veterinarians to vaccinate pigs against porcine circovirus type 2 (PCV2) and Mycoplasma hyopneumoniae with a single injection of FLEXcombo®. FLEXcombo®, a member of the FLEX Family™ of vaccines, is now available in a 50-dose presentation, in addition to a 250-dose presentation, giving producers and veterinarians a choice of sizes … Read More
Study Reveals Cattle Producers’ Most Important Vaccine Concerns
The Zoetis reproductive vaccine portfolio helps deliver what matters most to beef producers and veterinarians, including: infectious bovine rhinotracheitis (IBR) abortion prevention, demonstrated duration of immunity and safety, along with fetal protection. The new nationwide study investigates each of the most widely considered attributes when selecting a reproductive vaccine. Of the surveyed producers and veterinarians, 100% ranked IBR abortion protection, … Read More
Zoetis Granted Conditional License for PEDv
Zoetis Inc. announced that the U.S. Department of Agriculture (USDA) has granted a conditional license for a vaccine to help fight porcine epidemic diarrhea virus (PEDv) in pigs. The two-dose inactivated vaccine, licensed for use in healthy pregnant sows and gilts, is designed to help them develop antibodies that can be transmitted to their newborn piglets. Zoetis anticipates the vaccine … Read More
BIVI's New Vaccine Double Up Against Salmonella in Pigs
Veterinarians and producers now can protect pigs against two of the most virulent types of Salmonella with a single, convenient oral dose administered by the drinking water or oral drench. Boehringer Ingelheim Vetmedica, Inc. (BIVI) introduces a new swine enteric vaccine. Enterisol® Salmonella T/C is the only swine single-dose oral vaccine labeled as an aid in preventing disease due to … Read More
Combination Vaccine Gives Swine Industry Options
Fostera™ PCV MH — the porcine circovirus (PCV) and Mycoplasma hyopneumoniae (M. hyo) combination vaccine that was built from the ground up by Zoetis — now has the longest demonstrated duration of immunity (DOI) to help protect pigs from porcine circovirus-associated disease (PCVAD) caused by PCV Type 2 (PCV2). The U.S. Department of Agriculture has granted the combination vaccine the … Read More